Abstract

Background Exhaled nitric oxide is an easy noninvasive test, which is used for monitoring of different airway diseases. The aim of this study is to assess the usefulness of the fraction of exhaled nitric oxide (FeNO) in patients with chronic or recurrent coughing. Methods In this cross-sectional case- controlled observational study; we measured the (FeNO) level among children suffering from different chronic airway diseases (Asthma and Bronchiectasis). The study was conducted on 40 patients (5 years and up, both males and females) diagnosed clinically and radiologically as bronchial asthma (n = 20) and lung bronchiectasis of different aetiology (n = 20) compared to 40 age-and sex-matched controls. FeNO was measured using NO breath ® instrument (I. D. NBR022714, Bedfont Scientific Ltd, UK). It was significantly elevated in children with asthma compared to healthy controls (p Conclusion The study concluded that FeNO measurement is an important diagnostic test and screening biomarker for chronic paediatric airway diseases. Although FeNO can’t differentiate between causes of bronchiectasis, It can be used as a diagnostic test in PCD as it has significantly low levels.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call